PMN310 has been granted Fast Track Designation by the U.S. FDA for the treatment of Alzheimer’s disease.
| Date | Form | Description | Pages | |
|---|---|---|---|---|
| 07/29/25 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
| 07/29/25 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
| 07/28/25 | 8-K | Current report |
|
68 |
| 07/22/25 | 8-K | Current report |
|
137 |
| 07/22/25 | 424B5 | Prospectus [Rule 424(b)(5)] |
|
51 |
| 07/22/25 | 8-K | Current report |
|
3 |
| 07/07/25 | 8-K | Current report |
|
4 |
| 07/02/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
| 06/16/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
| 06/16/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |